Rare diseases
Investigational molecules
Locations
Back to Germany701 clinical trials in Munster, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus
GermanyStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
GermanyStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis
GermanyEvaluating mezagitamab in adults with late antibody-mediated rejection after kidney transplant
GermanyGermanyGermanyPhase 3 Study of Enfortumab Vedotin plus Pembrolizumab in Adults with Muscle‑Invasive Bladder Cancer Ineligible for Cystectomy
GermanySafety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH
GermanyGermanyPhase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease
GermanyStudy of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on lymphoma treatments and innovative therapies for breast cancer and lung cancer. Studies include evaluations of new combinations of targeted therapies and immunotherapy approaches.
Several trials are exploring novel treatment combinations and maintenance therapies for various blood cancers.
Comprehensive studies addressing obesity management and cardiovascular disease prevention. Research includes innovative approaches for weight management and heart failure risk reduction.
Multiple trials are investigating new therapeutic options for weight management and cardiovascular health improvement.
Innovative research in treating chronic skin conditions including plaque psoriasis and hidradenitis suppurativa. Studies focus on novel biological therapies and targeted treatments.
Trials are evaluating next-generation treatments for inflammatory skin conditions and immune-mediated disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
